Cohanzick Management, LLC Deciphera Pharmaceuticals, Inc. Transaction History

Cohanzick Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 10, 2022	SELL	$12.38 - $20.23 $18,570 - $30,345	-1,500 Reduced 75.0%	500 $9,000
Q4 2021 Feb 14, 2022	SELL	$7.7 - $37.13 $23,100 - $111,390	-3,000 Reduced 60.0%	2,000 $19,000
Q2 2021 Aug 13, 2021	BUY	$32.73 - $47.95 $32,729 - $47,950	1,000 Added 25.0%	5,000 $183,000
Q1 2021 May 14, 2021	BUY	$40.39 - $56.73 $80,780 - $113,460	2,000 Added 100.0%	4,000 $179,000
Q4 2020 Feb 12, 2021	BUY	$51.77 - $66.18 $103,540 - $132,360	2,000 New	2,000 $114,000

293K

500

Ticker DCPH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 66,822,100
Description
Deciphera Pharmaceuticals, Inc., a biopharmaceutical company, develops drugs to enhance the lives of cancer patients by addressing key mechanisms of drug resistance that limit the rate and durability of response to existing cancer therapies in the United States and internationally. Its lead drug candidate is QINLOCK used for the treatment of gas...

Get notified when there are updates to the investment portfolio of Cohanzick Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Cohanzick Management, LLC with notifications on news.